|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2006. View Article : Google Scholar
|
|
3
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Treeck O, Diedrich K and Ortmann O: The
activation of an extracellular signal-regulated kinase by
oestradiol interferes with the effects of trastuzumab on HER2
signalling in endometrial adenocarcinoma cell lines. Eur J Cancer.
39:1302–1309. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA
and Whang YE: Estrogen-receptor-dependent regulation of telomerase
activity in human endometrial cancer cell lines. Gynecol Oncol.
103:417–424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doll A, Abal M, Rigau M, Monge M, Gonzalez
M, Demajo S and Reventos J: Novel molecular profiles of endometrial
cancer-new light through old windows. J Steroid Biochem Mol Biol.
108:221–229. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gründker C, Günthert AR and Emons G:
Hormonal heterogeneity of endometrial cancer. Adv Exp Med Biol.
630:166–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uharcek P: Prognostic factors in
endometrial carcinoma. J Obstet Gynaecol Res. 34:776–783. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung TK, Cheung TH, Huen NY, Wong KW, Lo
KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, et al: Dysregulated
microRNAs and their predicted targets associated with endometrioid
endometrial adenocarcinoma in Hong Kong women. Int J Cancer.
124:1358–1365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo L, Yang Q, Lu J, Li H, Ge Q, Gu W, Bai
Y and Lu Z: A comprehensive survey of miRNA repertoire and 3′
addition events in the placentas of patients with pre-eclampsia
from high-throughput sequencing. PLoS One. 6:e210722011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Coppée JY: Do DNA microarrays have their
future behind them? Microbes Infect. 10:1067–1071. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benes V and Castoldi M: Expression
profiling of microRNA using real-time quantitative PCR, how to use
it and what is available. Methods. 50:244–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36(Database): D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu M, Shi B, Wang J, Cao Q and Cui Q: TAM:
A method for enrichment and depletion analysis of a microRNA
category in a list of microRNAs. BMC Bioinformatics. 11:4192010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhat KP and Pezzuto JM: Resveratrol
exhibits cytostatic and antiestrogenic properties with human
endometrial adenocarcinoma (Ishikawa) cells. Cancer Research.
61:6137–6144. 2001.PubMed/NCBI
|
|
19
|
Guo L, Sun B, Sang F, Wang W and Lu Z:
Haplotype distribution and evolutionary pattern of miR-17 and
miR-124 families based on population analysis. PLoS One.
4:e79442009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo L, Yang S, Zhao Y, Zhang H, Wu Q and
Chen F: Global analysis of miRNA gene clusters and gene families
reveals dynamic and coordinated expression. Biomed Res Int.
2014:7824902014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aravin AA, Lagos-Quintana M, Yalcin A,
Zavolan M, Marks D, Snyder B, Gaasterland T, Meyer J and Tuschl T:
The small RNA profile during Drosophila melanogaster development.
Dev Cell. 5:337–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du
ZW and Zhang JW: Human microRNA clusters: Genomic organization and
expression profile in leukemia cell lines. Biochem Biophys Res
Commun. 349:59–68. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ambros V, Bartel B, Bartel DP, Burge CB,
Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S,
Marshall M, et al: A uniform system for microRNA annotation. RNA.
9:277–279. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayashita YI, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Rese. 65:9628–9632. 2005. View Article : Google Scholar
|
|
25
|
Castellano L, Giamas G, Jacob J, Coombes
RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman
J, et al: The estrogen receptor-alpha-induced microRNA signature
regulates itself and its transcriptional response. Proc Natl Acad
Sci USA. 106:15732–15737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: from functions to
targets. PLoS One. 5:e130672010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Altuvia YI, Landgraf P, Lithwick G,
Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and
Margalit H: Clustering and conservation patterns of human
microRNAs. Nucleic Acids Res. 3:2697–2706. 2005. View Article : Google Scholar
|
|
29
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu J and Wong C: A computational screen
for mouse signaling pathways targeted by microRNA clusters. RNA.
14:1276–1283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ventura AI, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D and
Stone JR: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gregory PAI, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A,
Petrocca F, Martinvalet D, Song E, Lim B and Lieberman J: miR-200
enhances mouse breast cancer cell colonization to form distant
metastases. PLoS One. 4:e71812009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pecot CVI, Rupaimoole R, Yang D, Akbani R,
Ivan C, Lu C, Wu S, Han HD, Shah MY and Rodriguez-Aguayo C: Tumour
angiogenesis regulation by the miR-200 family. Nat Commun.
4:24272013. View Article : Google Scholar : PubMed/NCBI
|
